Creating a cost-effective, ultrafast, DNA-based tuberculosis test
for people all over the world


In PITBUL, a Horizon 2020 project, a consortium of international partners developed a rapid prototype test for the detection of Tuberculosis from sputum samples based on Pulse Controlled Amplification (PCA). This video provides insight in the steps to be performed in a fast and simplified, manual workflow and provides information about our assay.

PITBUL was established to help end Tuberculosis (TB) by developing an ultrafast test that can diagnose the disease in minutes. Current DNA-based detection of TB can take several hours.

The PITBUL ultrafast TB test can be cost-effective and affordable for low-resource communities with high TB burden. The test was designed to be used at the Point of Care, meaning settings where people infected with TB will first seek diagnosis, like hospitals, clinics and community centers.

PITBUL (Point-of-Care implementation of TB testing with ultrafast Local Heating PCR) has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 768889.